ADAM DAVENPORT: Open Payments
NPI 1922601921 · ALEX CITY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,146 in 56 payments from 17 companies in 2025. Trend: 2023 $782 · 2024 $781 · 2025 $1,146
Food & beverage: $1,146
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $149 |
| Actelion Pharmaceuticals US, Inc. | 8 | $148 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $146 |
| AstraZeneca Pharmaceuticals LP | 6 | $110 |
| United Therapeutics Corporation | 3 | $98 |
| Merck Sharp & Dohme LLC | 5 | $77 |
| PFIZER INC. | 3 | $68 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $61 |
| E.R. Squibb & Sons, L.L.C. | 3 | $60 |
| Novartis Pharmaceuticals Corporation | 3 | $48 |
Products named: Wegovy, Kerendia, FARXIGA, UPTRAVI, Tyvaso, VERQUVO, JARDIANCE, CAMZYOS.
Industry payments across AL — which companies pay providers there.
